◀ Back to PTBP1
HDAC1 — PTBP1
Text-mined interactions from Literome
Nencioni et al., Clin Cancer Res 2007
:
Here, we have evaluated the
effects of two
HDAC inhibitors currently in clinical use, sodium valproate and MS-275, on human monocyte derived
DCs
Kuriyama et al., Neuropharmacology 2013
:
The effectiveness of
D-cycloserine (DCS) , an N-methyl-D-aspartate glutamate receptor partial agonist, and valproic acid ( VPA ), a
histone deacetylase inhibitor , in facilitating the extinction of fear conditioned memory has been explored in humans and animals
Ye et al., J Cell Sci 2013
:
HDAC5-deficient mice have reduced cardiac
PTB protein abundance, and
HDAC inhibition in myocytes causes a reduction in endogenous expression of cellular FLICE-like inhibitory protein ( cFLIP ) and caspase dependent cleavage of PTB